Unknown

Dataset Information

0

Natural killer T cells mediate inflammation in the bile ducts.


ABSTRACT: Cholangiocytes function as antigen-presenting cells with CD1d-dependent activation of natural killer T (NKT) cells in vitro. NKT cells may act both pro- and anti-inflammatory in liver immunopathology. We explored this immune pathway and the antigen-presenting potential of NKT cells in the bile ducts by challenging wild-type and Cd1d-/- mice with intrabiliary injection of the NKT cell activating agent oxazolone. Pharmacological blocking of CD1d-mediated activation was performed with a monoclonal antibody. Intrabiliary oxazolone injection in wild-type mice caused acute cholangitis with significant weight loss, elevated serum levels of alanine transaminase, aspartate transaminase, alkaline phosphatase and bilirubin, increased histologic grade of cholangitis and number of T cells, macrophages, neutrophils and myofibroblasts per portal tract after 7 days. NKT cells were activated after intrabiliary injection of oxazolone with upregulation of activation markers. Cd1d-/- and wild-type mice pretreated with antibody blocking of CD1d were protected from disease. These findings implicate that cells in the bile ducts function as antigen-presenting cells in vivo and activate NKT cells in a CD1d-restricted manner. The elucidation of this biliary immune pathway opens up for potentially new therapeutic approaches for cholangiopathies.

SUBMITTER: Berntsen NL 

PROVIDER: S-EPMC6402771 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Natural killer T cells mediate inflammation in the bile ducts.

Berntsen N L NL   Fosby B B   Tan C C   Reims H M HM   Ogaard J J   Jiang X X   Schrumpf E E   Valestrand L L   Karlsen T H TH   Line P-D PD   Blumberg R S RS   Melum E E  

Mucosal immunology 20180816 6


Cholangiocytes function as antigen-presenting cells with CD1d-dependent activation of natural killer T (NKT) cells in vitro. NKT cells may act both pro- and anti-inflammatory in liver immunopathology. We explored this immune pathway and the antigen-presenting potential of NKT cells in the bile ducts by challenging wild-type and Cd1d<sup>-/-</sup> mice with intrabiliary injection of the NKT cell activating agent oxazolone. Pharmacological blocking of CD1d-mediated activation was performed with a  ...[more]

Similar Datasets

| S-EPMC3077894 | biostudies-literature
| S-EPMC6636344 | biostudies-literature
| S-EPMC7852842 | biostudies-literature
| S-EPMC6236558 | biostudies-other
| S-EPMC4897886 | biostudies-literature
| S-EPMC3186830 | biostudies-literature
| S-EPMC4546584 | biostudies-literature
| S-EPMC2995813 | biostudies-literature
| S-EPMC5336309 | biostudies-literature
| S-EPMC3061480 | biostudies-literature